<h2>Key Board Changes and Dividend Proposal</h2>
SYDNEY — Galderma Group AG has announced the details of its 2026 Annual General Meeting, set to take place virtually on April 22. The company has outlined a proposal for a dividend of 0.35 CHF per registered share, following a record performance in 2025, according to their official statement.
The agenda also includes significant proposed changes to the Board of Directors. L’Oréal nominees Delphine Viguier-Hovasse and <a href=”https://melbourne-insider.au/tag/samuel-du-retail/” title=”Samuel du Retail” rel=”noopener”>Samuel du Retail</a> are set to join as non-independent members, while Harry Kirsch, former CFO of Novartis, is proposed as an independent member, the company confirmed.
Current board members Michael Bauer and Marcus Brennecke will not seek re-election, as L’Oréal increases its investment in Galderma. Thomas Ebeling, Chair of the Board, expressed gratitude towards Bauer and Brennecke for their contributions, stating, “The proposed elections bring a strong and complementary range of experience to Galderma.”
Board Appointments and Leadership Changes
In addition to the new appointments, the board will vote on re-electing several current members, including Thomas Ebeling, Daniel Browne, and Maria Teresa Hilado, each for a one-year term. This reshuffling comes as Galderma aims to strengthen its leadership amid growing demand in the dermatology sector.
Galderma, a leader in dermatological solutions, operates in approximately 90 countries, offering a range of products across Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company’s strategic decisions reflect its ambition to solidify its position as an industry powerhouse. Galderma’s continuous investment in research and development demonstrates its commitment to innovation and quality, ensuring that its products meet the highest standards in dermatological care.
With these strategic moves, Galderma is poised to enhance its global footprint and continue its growth trajectory in the competitive dermatology market. The upcoming annual meeting is expected to set the stage for future developments and initiatives that will drive the company’s success in the years to come.
<p class=”rrp-source-attribution”>Source: <a href=”https://newshub.medianet.com.au/2026/03/galderma-publishes-invitation-and-agenda-for-its-2026-annual-general-meeting/144908/” target=”_blank” rel=”nofollow noopener”>newshub.medianet.com.au</a>
<p class=”rrp-related-link”>Related: <a href=”https://melbourne-insider.au/xiongan-urban-growth-model/”>Xiongan Leads Urban Growth Transformation</a>
Last updated: 29 June 2026, 12:29 pm
